Received: 27 May 2020
Accepted: 25 February 2021
First Online: 23 April 2021
: Not applicable.
: The manuscript includes two pictures of patients; we used our institutional consent forms which are available upon request.
: AK receives research support from AMO Pharma and consults to Ovid Therapeutics, Acadia, Ritrova, and Alkermes. The authors declare no competing interests.